R. Ruffmann

801 total citations
31 papers, 572 citations indexed

About

R. Ruffmann is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, R. Ruffmann has authored 31 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in R. Ruffmann's work include Immune Cell Function and Interaction (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Antifungal resistance and susceptibility (3 papers). R. Ruffmann is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Antifungal resistance and susceptibility (3 papers). R. Ruffmann collaborates with scholars based in Italy, United States and Germany. R. Ruffmann's co-authors include P Berthet, Étienne Grandjean, Philippe Leuenberger, Albrecht Wendel, Michael A. Chirigos, E. Schlick, Luigi Varesio, Tohru Saito, A. Sartani and M. A. Chirigos and has published in prestigious journals such as The Lancet, British Journal of Cancer and Urology.

In The Last Decade

R. Ruffmann

30 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ruffmann Italy 13 160 100 93 89 82 31 572
James C. Wallwork United States 19 153 1.0× 173 1.7× 100 1.1× 60 0.7× 55 0.7× 37 884
Birgit Jung Germany 15 237 1.5× 189 1.9× 155 1.7× 130 1.5× 49 0.6× 23 697
Haruko Mizoguchi United States 14 85 0.5× 135 1.4× 154 1.7× 98 1.1× 173 2.1× 20 640
Stephanie E. Easthope New Zealand 15 72 0.5× 169 1.7× 221 2.4× 62 0.7× 54 0.7× 23 830
Norihiro Saito Japan 15 148 0.9× 121 1.2× 314 3.4× 175 2.0× 53 0.6× 56 642
Shuji Yasui Japan 14 180 1.1× 292 2.9× 103 1.1× 177 2.0× 57 0.7× 19 704
Jane M. DeVasure United States 19 265 1.7× 162 1.6× 159 1.7× 166 1.9× 116 1.4× 36 811
Yuichi Yageta Japan 14 132 0.8× 255 2.5× 146 1.6× 164 1.8× 107 1.3× 14 665
Heinz‐Dieter Held Germany 10 223 1.4× 95 0.9× 149 1.6× 92 1.0× 84 1.0× 15 515
Stephen M. Spaethe United States 17 260 1.6× 179 1.8× 454 4.9× 210 2.4× 32 0.4× 48 829

Countries citing papers authored by R. Ruffmann

Since Specialization
Citations

This map shows the geographic impact of R. Ruffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ruffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ruffmann more than expected).

Fields of papers citing papers by R. Ruffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ruffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ruffmann. The network helps show where R. Ruffmann may publish in the future.

Co-authorship network of co-authors of R. Ruffmann

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ruffmann. A scholar is included among the top collaborators of R. Ruffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ruffmann. R. Ruffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grandjean, Étienne, P Berthet, R. Ruffmann, & Philippe Leuenberger. (2000). Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials. Clinical Therapeutics. 22(2). 209–221. 172 indexed citations
2.
Grandjean, Étienne, et al.. (2000). COST-EFFECTIVENESS ANALYSIS OF ORAL N -ACETYLCYSTEINE AS A PREVENTIVE TREATMENT IN CHRONIC BRONCHITIS. Pharmacological Research. 42(1). 39–50. 21 indexed citations
3.
Ruffmann, R. & Albrecht Wendel. (1991). GSH rescue by N-acetylcysteine. Journal of Molecular Medicine. 69(18). 857–862. 81 indexed citations
4.
Caine, Marco, et al.. (1991). Antispasmodic effects of flavoxate, MFCA,and REC 15/2053 on smooth muscle of human prostate and urinary bladder. Urology. 37(4). 390–394. 6 indexed citations
5.
Wiest, W., et al.. (1989). Comparison of Single Administration with an Ovule of 600 mg Fenticonazole versus a 500 mg Clotrimazole Vaginal Pessary in the Treatment of Vaginal Candidiasis. Journal of International Medical Research. 17(4). 369–372. 9 indexed citations
6.
Jung, E. G., et al.. (1988). Fenticonazole Cream Once Daily in Dermatomycosis, a Double-Blind Controlled Trial versus Bifonazole. Dermatology. 177(2). 104–108. 14 indexed citations
7.
Milani, Rodolfo, S. Scalambrino, S. Carrera, Patrick Pezzoli, & R. Ruffmann. (1988). Flavoxate Hydrochloride for Urinary Urgency after Pelvic Radiotherapy: Comparison of 600 mg versus 1200 mg Daily Dosages. Journal of International Medical Research. 16(1). 71–74. 11 indexed citations
8.
Ruffmann, R., et al.. (1987). Protein deficiency reduces natural antitumor immunity.. PubMed. 1. 15–27. 3 indexed citations
9.
Ruffmann, R., et al.. (1986). Proteinmangel, Körperabwehr und natürliche Anti-Tumor-Immunität. Transfusion Medicine and Hemotherapy. 13(2). 106–112. 1 indexed citations
10.
Ruffmann, R., et al.. (1986). Effect of Fenticonazole in Vaginal Candidiasis: A Double-Blind Clinical Trial versus Clotrimazole. Journal of International Medical Research. 14(6). 306–310. 19 indexed citations
11.
Ruffmann, R., et al.. (1986). [Protein deficiency, host defense and natural anti-tumor immunity].. PubMed. 13(2). 106–12. 3 indexed citations
12.
Schlick, E., et al.. (1985). Effects of poly(I,C)-LC on growth and differentiation of normal and malignant myelopoietic progenitor cells.. PubMed. 4(6). 628–33. 2 indexed citations
13.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.. PubMed. 45(3). 1058–65. 42 indexed citations
14.
Chirigos, M. A., et al.. (1985). Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].. PubMed. 4(6). 621–7. 3 indexed citations
15.
Saito, Tohru, et al.. (1985). Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers. Cancer Immunology Immunotherapy. 19(2). 130–5. 19 indexed citations
16.
Schlick, E., et al.. (1985). In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.. PubMed. 45(3). 1108–14. 7 indexed citations
17.
Schlick, E., et al.. (1984). Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.. Progress in clinical and biological research. 161. 467–79. 8 indexed citations
18.
Schlick, E., et al.. (1984). Biological characterization of MVE-2 and poly ICLC.. Progress in clinical and biological research. 161. 511–24. 1 indexed citations
19.
Ruffmann, R., et al.. (1984). In Vivo Activation of Macrophages but not Natural Killer Cells by Picolinic Acid (Pla). PubMed. 6(4). 291–304. 20 indexed citations
20.
Ruffmann, R., et al.. (1982). [Chemotherapy of head and neck squamous cell cancer with vindesine (Eldesine) and cis-platinum (Platinex) (author's transl)].. PubMed. 61(7). 406–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026